More than Rs 80 bn cash ready to take care of loan demand – Muthoot Finance

Update on the Indian Equity Market:
On Friday, Nifty50 ended higher at 11372 (+0.5%). Among the stocks, NTPC (+5.1%), POWERGRID (+4.6%), and ASIANPAINT (+4.4%) led the gainers. ZEEL (-3.7%), HINDALCO (-1.6%), and BHARTIARTL (-1.3%) led the losers. Among the sectoral indices, PSU BANK (+1.8%), BANK (+1.4%), and PRIVATE BANK (+1.3%) led the gainers. MEDIA (-1.4%), METAL (-0.6%), and IT (-0.3%) were the only losers.

Excerpts from an interview with Mr George Alexander Muthoot, MD, Muthoot Finance with ET Now on 20th August 2020:
• The past two months have been good and the going is great now as well. They are on track to reach or surpass the AUM estimate of about 15% growth. They are seeing good demand for gold loans since gold has been the buzzword recently. People are interested to associate with gold and gold financing is a part of it.
• Mr Muthoot believes it might be a little difficult for people to get credit via personal or housing loan, as lenders and NBFCs are not comfortable with fresh lending. Hence, for the next three-four quarters, there will be a good demand for gold loans.
• All their branches are open and people are able to come to the branches. The past two months has been a good growth period for their business and the momentum is likely to sustain. People are using gold to finance their requirements. Small businesses, small traders, and business people and individuals are using this.
• Gold price has also helped as people with lesser quantities of gold can have more gold loans in their hands. Unfortunately, the tonnage has not grown in line with the growth in AUM because newer loans need to bring only lesser quantities of gold.
• About 89-90% of the portfolio consists of gold loans which don’t have NPAs. NPAs are just loans which have crossed the threshold time limit. Auctioning the gold which is in NPAs is not beneficial as they have to refund money to the customer. Instead, they would give more time to the customer and pay it back and hold it as NPA in the books. None of the NPAs result in loan loss as the full interest and principal is recovered in time. This also keeps customers happy that their gold is not being auctioned off.
• For about 10% of the loan book which is in vehicle finance, housing finance, they have given moratorium to customers.
• Standard provisioning and loan loss provisioning is applicable to them just as to NBFCs. There are about Rs 10 bn provisions in terms of standard assets or loan loss provisions. This is just a technical provision and he never sees it converting into loan loss.
• There is no plan of acquiring any gold loan company since the average tenure is four months only. By the time negotiation with the company is done the loan would have gone off their books.
• The regular growth through 5,000 branches is sufficient for them because the average branch business is about Rs 10 crore and any branch can cater to double that. So an average of Rs 20 crore per branch is easily sustainable for them.
• In South India, both the public and private sector banks are advertising about giving gold loans. Banks coming into this space is good as it gives more credibility and visibility to this business. There are about 25,000 tons of gold in the market with the public and only about 3,000 tons is in the organised gold loan sector. Since there is a lot of gold which has not come into the gold loan market, there is a place for everybody.
Consensus Estimate: (Source: market screener and investing.com websites)
• The closing price of Muthoot Finance was ₹1,181/- as of 21-August-2020. It traded at 3.4x/ 2.7x the consensus book value estimate of ₹ 352/438 for FY21E/ FY22E respectively.
• The consensus target price of ₹ 1,195/- implies a PB multiple of 2.8x on FY22E BV of ₹ 428/-.
Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Execution back on track with return of labour and availability of raw materials: Dilip Buildcon

Update on the Indian Equity Market:
On Thursday, NIFTY closed in red at 11,312 (-0.8%). Top gainers in NIFTY50 were NTPC (+6.9%), ONGC (+3.3%), and Power grid (+2.6%). The top losers were Tata Motors (-2.6%), HDFC (-2.3%), and Axis bank (-2.2%). The top sectoral gainers were MEDIA (+3.1%), METAL (+1.0%) and REALTY (+0.4%) and sectoral losers were FIN SERVICES (-1.3%), PVT BANKS (-1.3%), and BANK (-1.3%).

Excerpts of an interview with Mr Rohan Suryavanshi, Head -Strategy & Planning, Dilip Buildcon with ET now dated 18th August 2020:
● 1QFY21 was impacted by Covid but the good news is that they have had a very strong order book. The Rs 8,900 crore worth of orders that they have won are spread across different verticals.
● They have dam irrigation orders, tunnel orders, special bridge orders and also road orders. All these have different lead times of two to four years and these orders will start sort of giving revenues in the later part of this year which would be about the end of Q3FY21 to the start of Q4FY21.
● Execution has definitely picked up from when the lockdown was imposed. They have started seeing reverse migration of now labourers coming back to sites. They have also started seeing normalisation in all the raw material supply chains which has been disrupted.
● 90% plus of their labourers have come back to the sites and all the raw material disruptions are behind barring some sites where there might be local disruptions.
● The only thing that is impacting right now are the monsoons. Since they have had good monsoons across the country that is impacting work for the industry as a whole.
● For the past couple of years, they have been focussing on debt reduction and working capital cycle improvement which had also seen their debt equity ratio falling to 0.81 last year from 1.06 a year before.
● In FY21, because of Covid and because of the impact that it has had, they will avail of a moratorium, and also avail of whatever facilities the RBI has given them.
● Current debt numbers and the current working capital cycle numbers will not go up from here and will actually reduce and this is all obviously dependent on how the rest of the year looks and hopefully they would not have any more large disruptions or shutdowns because all those things will impact revenue and profitability.
● In 1QFY21, their revenues were only reduced by about 17% as a YoY basis from same quarter last year, which is exceptionally good as opposed to the industry average of about 40% plus reduction in revenues.
● The business model of having their own people, having their own equipment, doing everything on their own without any subcontracting has definitely helped them in getting this revenue and being ahead of the curve when the recovery came.

Consensus Estimate: (Source: market screener and investing.com websites)

● The closing price of Dilip Buildcon was ₹ 404/- as of 20-August-2020. It traded at 18x/ 11x the consensus earnings estimate of ₹ 22.0/ 37.7 for FY21E/22E respectively.
● The consensus price target is ₹ 406/- which trades at 11x the earnings estimate for FY22E of ₹ 37.7/-
Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Home-delivery of alcohol will take time to build scale – United Breweries

Update on the Indian Equity Market:
On Wednesday, Nifty ended 0.2%, higher than the previous close at 11,408. The top gainers for Nifty 50 were Zee (+14.1%), GAIL (+5.0%), and Tech M (+2.2%) while the losing stocks were Bajaj Auto (-1.2%), ONGC (-1.2%), and Nestle (-1.0%). The sectoral gainers for the day were Media (+5.4%), PSU Bank (+2.4%) and Realty (+1.3%) while the losers were FMCG (-0.4%), Pharma (-0.4%), and IT (-0.3%).

Edited excerpts of an interview with Mr Rishi Pardal, MD & CEO, and Mr Debabrata Mukherjee, CMO, United Breweries Ltd; dated 17th August 2020 from Mint:

• The quarter that went by (April-June) was very unusual, impacted by the pandemic and lockdowns. For more than 50% of the quarter, the Company was physically shut. At the beginning of the pandemic, large increases in taxation also impacted demand.
• In quarter two, the story is mirroring the progression of the pandemic. As governments are easing restrictions they are starting to see a similar thing come into the business. But it’s a long road ahead. There are a lot of starts and stops. A sudden spike in local cases can shut the market for a few days, so it’s too early to talk of recovery right now, as per Mr Pardal.
• The Company’s focus is on managing costs. All discretionary expenses that can be avoided such marketing spends, which may be specifically driven towards either particular innovations or events that are not happening, are avoided. At the same time, they are a consumer products company, so they need to make sure that they cannot be silent or absent in the mind of the consumer.
• Beer is seeing a latent demand for United Breweries. If there is a physical fulfilment opportunity where a consumer can access the outlets, or the Company can encourage online order and home delivery, or look at reviving consumption in bars – the latent demand is there. The problem is more of a supply-side issue.
• Alcohol is a highly restricted category, with a lot of stringent rules. So the fact that a few state governments are now beginning to sort of consider the online sales and home delivery is really positive development for the Company.
• United Breweries is partnering with the online aggregators, with delivery services and people engaged in the space. But this will take time. This is a nascent opportunity. Over a period of time, more states will follow suit and the channel will build scale.
• 60% of channels have opened up.
• The Company is working with IPL teams to figure out how best they can leverage the change in venue opportunity. It will be using a sporting event of this nature to connect with their consumer. So the money outlay is based on that brand strategy requirement.

Consensus Estimate: (Source: market screener website)
• The closing price of United Breweries India was ₹ 1,016/- as of 19-August-2020. It traded at 423x/42x/37x the consensus EPS estimates of ₹ 2/24/28 for FY21E/FY22E/23E respectively.
• The consensus target price of ₹ 1,056/- implies a PE multiple of 38x on FY23E EPS of ₹ 27.7/-.
Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Working toward becoming a technology and IP driven organization- PIIND

Update on the Indian Equity Market:

On Tuesday, Nifty closed 1.2% higher at 11,385. Within NIFTY50, GRASIM(+6.5%), ULTRACEMCO (+3.3%), and JSWSTEEL (+3.1%) were the top gainers, while BPCL (-1.2%), TECHM (-0.9%) and CIPLA (-0.8%) were the top losers. Among the sectoral indices, REALTY (+4.0%), PVT BANK (+2.2%), BANK (+2.2%), and MEDIA (+2.2%) gained the most. PHARMA (-0.1%) was the only sector to end with losses.

Working toward becoming a technology and IP driven organization- PIIND

Excerpts of an interview with Mr. Mayank Singhal, MD&CEO, PI Industries (PIIND) published on Economic times website dated 12th August 2020:
• The companyplans to invest the Rs 20,000 mn QIP funds across different categories over the next 2 quarters. One way is into inorganic opportunities to get into complementary adjacencies- including pharmaceuticals. The other way is by acquisition of smaller blocks which could be synergistic and complementary in terms of technology.
• PIIND has 1 or 2 branded products that it plans to launch in the Indian domestic market in FY21. They also plan to commercialize 2 new products for the global contract manufacturing business.
• Over last 5-6 years, PIIND has made aggressive investments in R&D to become a more knowledge-based partner. They are working towardbecoming more of a technology and IP driven organization over next 4-5 years.
• Mr. Singhal expects India to fare well in the global shift in manufacturing. If supported through strong policies in the area of manufacturing chemical industry, India could move to the next level. India should specifically focus towards IP generation and creation which wouldbe an edge over the Chinese competition.
• In India about 50-60% of agriculture is dependent on monsoons. PIIND has 30-40% of its revenue dependent on India. Considering good monsoons currently, PIIND like all India business-based companies will do well.
• PIIND is supplying an intermediate to a Japanese client, for a drug approved for Covid-19 treatment. PIIND is also looking to supply the intermediate to Indian producers entering into the space.
• PIIND plans to grow aggressively in next 3-4 years by utilizing its competency in chemistry and technology. With that into perspective, PIIND has also recently filed 7 patent applications based on process in chemistry capabilities.
Consensus Estimate (Source: marketscreener website)
• The closing price of PIIND was ₹ 1,965/- as of 18-Aug-2020. It traded at 44.6x/ 35.2x/ 28.7x the consensus EPS estimate of ₹ 44.1/ 55.8/ 68.5 for FY21E/ FY22E/ FY23E respectively.
• The consensus target price of ₹ 2,014/- implies a PE multiple of 29.4x on FY23E EPS of ₹ 68.5.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

‘Even with Covid, our fresh slippages will be in control’ – SBI

Update on the Indian Equity Market:
On Monday, NIFTY ended up 81 pts (+0.7%) at 11,259.
Among the sectoral indices, MEDIA (+2.6%), AUTO (+2.4%) and METAL (+2.5%) were top gainers while PSUBANK (-0.5%) and PHARMA (-0.3%) were the losers.
Among the stocks, NTPC (+7.5%), EICHERMOT (+4.8%) and ZEEL (+4.7%) were the top gainers. SBI (-1.6%), BHARTIARTL (-1.5%) and BPCL (-1.3%) were the top losers.

‘Even with Covid, our fresh slippages will be in control’ – SBI

Edited excerpts of an interview with Mr. Rajnish Kumar, Chairman of SBI with Business Standard dated 14th Aug, 2020:

SBI Chairman Rajnish Kumar doesn’t see any reason to fear a sudden rise in bad debt during the pandemic. Legacy loans are well taken care of, the bank has enough capital, and the exposure to sectors affected by the Covid-19 stress is minuscule in relation to the balance sheet.

• His comments on restructuring of retail loans: SBI team is working on what the policy would be and to whom the relief should be extended. But mostly, the relief, if needed, would be for housing loans where a person has lost a job and is unable to pay his EMI or there’s been a temporary salary cut. In the case of SBI, the housing loan book under moratorium is about ~ Rs 32,000 crore. But he believes most customers would start paying EMIs from September as the moratorium comes to an end. But whoever needs relief should get it.
• When asked whether banks will have enough time to prepare resolution for all under the latest restructuring scheme, he replied that he doesn’t think they will have to wait for the RBI for such an exercise. There are not many accounts in the corporate group of ~ Rs 1,500 crore and above which would need to go to the committee because a lot of work has already happened under the June 7 framework. There will be some modalities that the committee will suggest, but the ground work such as who would need restructuring, their projections, estimations, etc., can be done.
• His views on banker’s ability to project the topline and bottom line: Future projection is the first thing that is considered in any proposal. Of course, the Covid-19 scenario brings in a lot of uncertainty. Nobody knows how long the pandemic will continue and what the revival plan will be. When you give credit or restructure, it’s based on certain assumptions, and even the current exercise will have to return to those assumptions, particularly for the term loans. The maximum one can postpone or restructure the instalments is for two years. So, whoever had to pay in five years will have to pay now in seven years. Another criterion is that the account should be performing. Whatever you have to do is within these two boundaries.
• When asked if SBI will need additional funds for the restructuring exercise he informed that the bank already has Rs 20,000 crs as an enabling provision. SBI will need to raise money from the equity market only if there is a growth in assets, for any sort of provisions for bad loans. For any risk capital, SBI have sufficient earnings and have the value sitting in subsidiaries.
• He stated that restructuring for retail has come for the first time, and is sure that lenders will make their assessment of portfolio. Moratorium by itself is not a pointer that everybody would apply or need restructuring. In the case of SBI, housing loans worth Rs 32,000 crore are under moratorium where zero or one installment has been paid. He believes many of them will start paying from September as moratorium was available and they were preserving cash. The loan to value for SBI in this segment is 60%. The restructuring would be needed in cases where income was impacted which is not a huge number and hence, any fear of large-scale restructuring is uncalled for.
• When asked whether he is concerned about the NPA situation if the pandemic lingers, he said that the scenarios are not uniform for every bank or every institution, it depends on the underwriting practices, or to which sectors they are exposed to, and what their level of risk diversification is. When negative growth is expected, it is natural that stress in the system will go up. It is a wait and watch situation for everyone. In the last three years, most banks have done a lot of clean-up and provision coverage ratio are at an all-time high. As for SBI, the provision coverage ratio (PCR) has improved from 61 to more than 86 per cent. Legacy NPA today is 1.86 per cent, and it was 5 per cent plus.
• He further commented on bad debt impact for SBI: He informed that SBI’s legacy costs are very minimal. As an example, today, in the corporate book, SBI’S net NPA is Rs 10,500 crore. Just one quarter’s earnings are sufficient to make it zero. The corporate book has no legacy credit cost left. In baseline scenario, not accounting for Covid, it is 1-1.5 per cent of slippages. Considering Covid, he believes in the worst-case scenario this 1.5 per cent can become 2.5-3 per cent. SBI’s exposure to the sectors impacted by Covid-19 is minuscule in relation to the size of the balance sheet.

Consensus Estimate: (Source: market screener, investing.com websites)

• The closing price of SBI was ₹ 193/- as of 17-Aug-2020. It traded at 0.76x/0.7x/0.64x the consensus book value estimate of ₹ 258/279/305 per share for FY21E/ FY22E/ FY23E respectively.
• The consensus target price of ₹ 265/- implies a PB multiple of 0.86x on FY23E BVPS of ₹ 305/-

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

85% of stores are open – Bata India

Update on the Indian Equity Market:
On Friday, Nifty closed 1.1% lower at 11,178. Among the sectoral indices PSU banks (-2.3%), Auto (-2.6%) and Bank (-2.3%) closed lower. Pharma (+1.4%) and Metal (+1.1%) closed on a positive side. Eicher Motors (-7.2%), Tata Motors (-4.8%) and M&M (-3.3%) closed on a negative note. JSW Steel (+2.6%), Coal India (+2.3%), and Sun Pharma (+2.0%) were among the top gainers.

Excerpts from an interview of Mr. Ashwani Windlass, Chairman, Bata India with Business Line on 13th August 2020:

• The market place is still uncertain. There are intermittent lockdowns happening and the pandemic is surging in different places.

• Consumers are still not going out as they use to go before and that puts a question in terms of demand.

• Categories like sports, chappals, sandals and casuals are more popular and are moving faster, as opposed to formal footwear.
• This behaviour is also justifiable with the current scenario as there are not many social gatherings and people are not going to offices.

• The company is responding to the trends through offerings in stores and also on digital campaigns.

• Markets are opening up but the footfall is less. Factories are also working with staff limitations.

• Key metros like Delhi, Mumbai, Chennai are showing positivity.

• The company is hopeful that after the current ‘End of Season’ sale, some demand will be back in festival season

• Tier-I towns in India, including metros, are more congested, and they witnessed a different level of surge first. Now, the spread is into tier-II or tier-III towns. For example, the tier-II towns in Karnataka and Kerala were doing well before the surge happened there.

• The impact in smaller cities will not be as much as what it is in the metros that has the bulk of the demand.
• At this moment, Bata is supplying what customer wants.

• On new store openings, Bata adds 50 retail outlets which are company-owned and at least 50 which are franchisee-owned in a normal year. However, this year the company will focus on cash conservation and look for franchisees.

Consensus Estimate: (Source: market screener & Investing.com websites)
• The closing price of Bata India was ₹ 1,234/- as of 14-August-2020. It traded at 218x/40x/34X the consensus earnings per share estimate of ₹ 5.6/30.5/35.9 for FY21E/FY22E/FY23E respectively.
• The consensus average target price for Bata India Ltd is ₹ 1,296/- which implies a PE multiple of 36x on FY23E EPS of ₹ 35.9/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Times that try stock picker’s soul

Drew Dickson points out that there is one way to generate excess stock market returns over the long term, and it isn’t to “own winners at any price.” Sure, in hindsight it was, but that is very convenient. It’s very convenient to now ignore the stocks we thought were winners but weren’t. It’s also very convenient to draw parallels between past winners and newer companies as if it is a foregone conclusion they too will win in a similar fashion. Nor do excess returns come from “owning good companies at any price” or “owning high-quality companies at any price.” The “one way” to outperform is to buy a concentrated portfolio of securities that Mr Market doesn’t own; names which are shunned because Mr Market has become overly pessimistic about the fundamental prospects for businesses that are better than he believes or realizes. That’s it. That’s the formula.
This often isn’t sexy, it often isn’t fashionable, and it often isn’t fun. However, a successful investor outperforming Mr Market over the long term owns companies that, by definition, Mr Market believes are pretty stupid to own.
Instead, Mr Market often thinks growing, glamorous, names are much smarter to own. They definitely are smarter looking. And it is surely more entertaining to own these stocks. It’s also easier to sleep at night. They are obviously more dynamic companies and, in many cases, they indeed are better companies. And there are periods where these growing, good and glamorous names do tremendously, well. During these episodes, it downright sucks to be a fundamentally-driven value investor. Equity markets had one of those periods in 1998-1999, and – in Dickson’s view – they may be having another one of them now. Paraphrasing Thomas Paine, these are the times that try stock-pickers’ souls.
The stock market, at least at the moment, seems most sensitive to whether or not a company is classified as a “good” or “bad” business. And “good” means your stock has already appreciated, is already expensive, and is showing even the slightest degree of business momentum. And no price is high enough for “good”. Because good is good, so why wouldn’t you own it? “Bad” is the opposite. Bad is an already-inexpensive stock that has already sold off, and one that has already exhibited fundamental weakness, even if it’s likely a short-term phenomenon. And no price is low enough for “bad”. Because bad is bad, so why would you own it? As maddening as this behaviour is, it is typical of investor psychology at peaks and troughs; and consequently, the “price” of growth is higher than it has ever been.
Dickson asserts that there is no new era. Stocks are still worth the present value of their future cash flows. While narratives can dominate in the short term, and while the short term is sometimes longer than we like, the fundamentals eventually matter. They have to. We are buying fractions of the equity value of large, liquid, listed, enterprises. The fundamentals “have to matter” because these fractions of equity, these shares, are worth the present value of all future cash flows to that fraction of ownership. We have no idea when “eventually” is going to arrive. Whether or not we are three days or three years away from this growth bubble popping, he doesn’t know. But he is tremendously confident that it isn’t “different this time.”

Making structural changes to diversify from auto industry – JSW Steel

Update on Indian equity market:
Nifty remained muted on the weekly expiry day, ending 8 points lower at 11,300. Within NIFTY50, TATAMOTORS (+4.5%), LT (+4.4%) and HINDALCO (+4.2%) were the top gainers while SUNPHARMA (-2.1%), EICHERMOT (-2.1%) and BHARTIARTL (-2.0%) were the top losers. Among the sectoral indices, MEDIA (+1.4%), AUTO (+1.2%) and METAL (+1.1%) were the highest gainers whereas PSU BANKS (-1.0%), PHARMA (-0.9%) and BANK (-0.3%) were the laggards.
Excerpts of an interview with Mr. Seshagiri Rao, Joint Managing Director & CFO, JSW Steel (JSW) published in Economic Times dated 04th August 2020:
•Mr Rao said that in the normal scenario, the company was supplying about 2 million tonne to the Auto sector from the total annual capacity of 15 million tonne. During the pandemic lockdown, the number had dropped by as much as about 65%.
•The company is witnessing demand for steel picking up in tractors and two-wheelers. The demand from top-2 passenger car makers, Maruti and Hyundai has been improved in July over June. The demand for steel in the commercial vehicles segment however remained depressed.
•The company’s alloy steel plant at Salem produces about 1 lakh tonne out of which 70,000 tonne capacity is on rolling basis. There is one bloom mill completely dedicated to the auto sector, and there is a bar mill which can have multiple applications, and finds use in the sectors other than the auto also.
•In the lockdown, the bar mill production was not reduced, whereas the bloom mill production came down to 0 in the month of April, which is currently operating at 10,000- 15,000 tonne a month.
•The changes that company is making on the Auto side are not temporary, they are all structural. The growth in demand for steel from the Auto sector is not the same as the industry has witnessed in the past. He expects it to never be the same and therefore diversification has a strategic component with itself.
Consensus Estimate: (Source: market screener website)
•The closing price of JSW Steel was ₹ 259/- as of 13-Aug-2020. It traded at 38x/13x/ 9x the consensus EPS estimate of ₹ 6.8/ 20.5/ 27.8 for FY21E/ FY22E/ FY23E respectively.
•Consensus target price of ₹ 233/- implies a PE multiple of 8x on FY23E EPS of ₹ 27.8.
Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

An opportunity to re-imagine business – Cipla

Update on the Indian Equity Market:
On Wednesday, Nifty50 snapped its six-day winning streak to end 0.1% lower at 11,308. HCLTECH (+4.7%), SBIN (+4.3%), and TECHM (+2.8%) ended the day in the green. KOTAKBANK (-2.1%), CIPLA (-2.1%), and SUNPHARMA (-2.0%) led the laggards. Among the sectoral indices, PSUBANK (+2.7%), MEDIA (+2.4%), and AUTO (2.0%) led the gainers while PHARMA (-1.6%), REALTY (-0.7%), and METAL (-0.7%) led the losers.

Cipla recently declared 1QFY21 results. Mr. Umang Vohra, MD & Global CEO discussed the opportunities provided by the covid epidemic to the business with Economic Times on 11th August 2020. Here are the edited excerpts of the interview:

• He outlined three reasons for the good numbers reported. The first being that healthcare is a part of essential services continues to work despite the pandemic led lockdowns. The second being the tailwinds of the crisis is the increased levels of collaboration and cooperation with every healthcare authority in the world. The third reason being getting more Covid treatments out as soon as possible and ensuring drug supply is not affected.
• The Covid crisis has given an opportunity to reimagine their business. It has given an opportunity to understand what is important to running their business. There were a few costs that could not be incurred. Since all the manufacturing plants are operating, those costs have increased slightly as more precaution for social distancing needs to be taken. The absence of some of the field costs has helped the bottom line.
• The timelines of approvals are at an all-time high and in terms of pricing, the only market that was a concern was the US. In the US, more attention is paid to the availability of the product against price.
• Respiratory is the core therapy for Cipla and they are trying to expand their respiratory franchise. Albuterol is the first one and there is a reasonable pipeline built for unlocking the respiratory franchise in the US over the next 18-24 months.
• Albuterol production has ramped up quite significantly in the first quarter and it being a 60-million-unit market, Cipla will get its fair share in the market.
• Some of the cost control measures were voluntary and some were involuntary. Due to lockdowns, travel costs were not incurred. Some of that would resume again in the coming quarters. There is an ambitious cost program which has been running for the past 2-3 years and which will continue to run.
• The guidance for margins has been to the same level before lockdown; as a large portion of the cost base cannot be maintained so low. So the sustainable basis for every quarter is going to be slightly lower than the first quarter in absolute percentage terms.
• With the crisis lasting a little longer in India, chronic conditions will continue to stay the same. The respiratory linked illnesses, linked to weather and linked to winter will continue. Acute therapy is impacted as patients are healthier and not reporting sick. Hospitals are beginning to uptick now and expect to see a resumption of surgeries and elective procedures in a quarter’s time.
• Cipla’s business is changing and about 15-20% of its market will be very different compared to pre-covid.
• Digital has the ability to penetrate healthcare more significantly compared to physical representatives. Digital provides remote connect which is faster and economical.

Consensus Estimate: (Source: market screener website)
• The closing price of Cipla was ₹ 762/- as of 12-August-2020. It traded at 29x/ 25x/ 21x the consensus earnings estimate of ₹ 26.2/ 30.2/ 36.7 per share for FY21E/FY22E/FY23E respectively.
• The consensus target price of ₹ 769/- implies a PE multiple of 21x on FY23E EPS of ₹ 36.7/-.

Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”

Healthcare and hygiene portfolio has grown by 29% in Q1 – Emami

Update on the Indian Equity Market:
On Tuesday, NIFTY closed in the green at 11,322 (+0.5%). Top gainers in NIFTY50 were Zee (+5.2%), JSW Steel (+3.9%), and Axis bank (+3.9%). The top losers were Shree Cement (-3.9%), Titan (-3.6%), and UPL (-2.3%). The top sectoral gainers were MEDIA (+1.9%), PVT BANK (+1.7%) and METAL (+1.6%) and sectoral losers were PHARMA (-1.4%), IT (-0.5%), and REALTY (-0.5%).

Excerpts of an interview with Mr NH Bhansali, CEO, Emami with ET now dated 10th August 2020:

● April was impacted badly. They progressed well in May and in June they grew in single digit. The July trajectory is also good. They grew in double digits in July and they expect the growth to resume.
● On the international front also, while they have declined in the first quarter but in the second quarter, they expect to improve on the international front as well. They expect moderate growth in 2QFY21.
● The healthcare and hygiene portfolio has grown by 29% in Q1FY21 and it contributed around 43% of the turnover in the first quarter. While the summer brands and other brands including the male grooming all de-grew by 44%.
● This pulled down the overall growth which contributed around 57%. Going forward they expect good growth from the healthcare and hygiene products kind of sanitizers.
● new launches there in the healthcare and sanitizers like Boroplus Sanitizer, soaps, aloe vera gel, zandu immunity range, chyawanprash they all contributed around 5% of the turnover.
● Navratna and others were declining in the first quarter but now in June-July they have started recovering. Kesh King range was declining in April-May but cumulatively in June, the Kesh King range has been able to wipe out its losses.
● It is stable now, it has maintained its growth and they expect now the growth to come in in the second quarter. Summer brands have also now started picking up while the decline earlier was higher but in June-July the decline has been lesser.
● The gross margins have reduced by 230 bps and EBITDA margins has improved by 480 bps. The gross margin has been mainly because of the benign cost and they expect this kind of margins to continue.
● On the EBITDA level, they had taken many initiatives, right from reducing on the advertisements which was not required in the April as they were completely off air in April, May and June now gradually they are resuming some of the advertisements
● They have internally targeted to improve their costs by around Rs 80-100 crore in the next 12 months and they are well on the path and they would continue to achieve it.
● They have made 12 new launches in this quarter and which were all around health and hygiene and sanitizers and all. In the times to come, they are planning to get into the home hygiene products which may include disinfectants, toilet cleaners and bathroom cleaners and other things.
● Rural demand has picked up well, in fact, it is visible in the rural areas compared to the urban but there is no significant down trading on LUPs.
● They have initiated so many things, they have done digital marketing because their focus is more on addressing the consumers digitally without physical touch so while the retail and modern trade has been impacted, and they are exploring other channels also.
● They are doing a lot many initiatives by telemarketing, digital marketing, tele-calling for taking the orders and ensuring that the supplies are done on time. In fact, the E-commerce business has more than doubled in this first quarter despite such a decline and it is continuing to grow.

Consensus Estimate: (Source: market screener and investing.com websites)

● The closing price of Emami was ₹ 337/- as of 11-August-2020. It traded at 34x/ 31x the consensus earnings estimate of ₹ 9.9/ 10.8 for FY21E/22E respectively.
● The consensus price target is ₹ 301/- which trades at 28x the earnings estimate for FY22E of ₹ 10.8/-
Disclaimer: “The views expressed are for information purposes only. The information provided herein should not be considered as investment advice or research recommendation. The users should rely on their own research and analysis and should consult their own investment advisors to determine the merit, risks, and suitability of the information provided.”